ATE271788T1 - Lacto-n-neotetraose enthaltende ernährungszusammensetzungen - Google Patents

Lacto-n-neotetraose enthaltende ernährungszusammensetzungen

Info

Publication number
ATE271788T1
ATE271788T1 AT98913279T AT98913279T ATE271788T1 AT E271788 T1 ATE271788 T1 AT E271788T1 AT 98913279 T AT98913279 T AT 98913279T AT 98913279 T AT98913279 T AT 98913279T AT E271788 T1 ATE271788 T1 AT E271788T1
Authority
AT
Austria
Prior art keywords
neotetraose
compositions containing
nutritional compositions
lacto
containing lacto
Prior art date
Application number
AT98913279T
Other languages
English (en)
Inventor
Pedro A Prieto
Terry A Kroening
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE271788(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE271788T1 publication Critical patent/ATE271788T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
AT98913279T 1997-03-31 1998-03-30 Lacto-n-neotetraose enthaltende ernährungszusammensetzungen ATE271788T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/829,220 US5906982A (en) 1997-03-31 1997-03-31 Nutritional formulations containing Lacto-N-neoTetraose
PCT/US1998/006217 WO1998043495A1 (en) 1997-03-31 1998-03-30 Nutritional formulations containing lacto-n-neotetraose

Publications (1)

Publication Number Publication Date
ATE271788T1 true ATE271788T1 (de) 2004-08-15

Family

ID=25253891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98913279T ATE271788T1 (de) 1997-03-31 1998-03-30 Lacto-n-neotetraose enthaltende ernährungszusammensetzungen

Country Status (11)

Country Link
US (2) US5906982A (de)
EP (1) EP0973413B2 (de)
JP (1) JP4148535B2 (de)
AT (1) ATE271788T1 (de)
CA (1) CA2285066C (de)
DE (1) DE69825260T3 (de)
DK (1) DK0973413T4 (de)
ES (1) ES2229486T5 (de)
NO (1) NO315254B1 (de)
PT (1) PT973413E (de)
WO (1) WO1998043495A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6375994B1 (en) * 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
EP1062873A1 (de) * 1999-12-13 2000-12-27 N.V. Nutricia Verbessertes Säuglingsnährpräparat, Eiweisshydrolysat zur Verwendung in solchem Säuglingsnährpräparat, und Verfahren zur Herstellung solches Hydrolysates
DE60301677T2 (de) * 2002-02-04 2006-07-06 Kyowa Hakko Kogyo Co., Ltd. Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert
US20040047866A1 (en) * 2002-09-09 2004-03-11 President And Fellows Of Harvard College Immunomodulatory methods using carbohydrate antigens
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
ATE361101T1 (de) 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
CN101155516B (zh) * 2005-04-08 2012-10-03 雪印惠乳业株式会社 含乳蛋白的铁组合物
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
MX2010005132A (es) * 2007-11-08 2010-06-02 Nestec Sa Uso de oligosacaridos conteniendo n-acetilactosamina para maduración de las respuestas inmunes en neonatos.
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2400839B1 (de) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und verwendungsverfahren dafür
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
EP2465508A1 (de) * 2010-11-23 2012-06-20 Nestec S.A. Zusammensetzung mit hydrolysierten Proteinen und Oligosacchariden zur Behandlung von Hautkrankheiten
WO2012092082A1 (en) * 2010-12-30 2012-07-05 Abbott Laboratories Reduced buffering capacity of a low calorie infant formula
US20120171166A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
BR112013016903A2 (pt) 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para modular inflamação
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
MY196432A (en) 2010-12-31 2023-04-10 Abbott Lab Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PL2768313T3 (pl) * 2011-10-18 2016-02-29 Nestec Sa Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie
WO2013161820A1 (ja) 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
CN104853621A (zh) * 2012-12-20 2015-08-19 雅培制药有限公司 使用人乳寡糖用于调节炎症的营养制剂
EP3229812A4 (de) 2014-12-08 2018-10-03 Glycom A/S Synthetische zusammensetzung zur behandlung von stoffwechselerkrankungen
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) * 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN107404925A (zh) 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
ES2772685T3 (es) 2015-08-04 2020-07-08 Nestle Sa Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
MX2018015187A (es) 2016-08-04 2019-04-24 Nestec Sa Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
JP7854503B2 (ja) * 2022-07-29 2026-05-01 森永乳業株式会社 ビフィドバクテリウム・ブレーベのオリゴ糖資化促進用組成物
WO2025083288A1 (en) 2023-10-19 2025-04-24 N.V. Nutricia Mixture of human milk oligosaccharides
WO2025083289A1 (en) 2023-10-19 2025-04-24 N.V. Nutricia Mixture of human milk oligosaccharides
CN120859173B (zh) * 2025-09-28 2026-04-17 内蒙古乳业技术研究院有限责任公司 可提升矿物质锌的生物利用度的母乳低聚糖及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE518409A (de) *
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE462134B (sv) * 1987-10-22 1990-05-14 Biocarb Ab Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
WO1991016449A1 (en) * 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
AU692841B2 (en) * 1994-03-09 1998-06-18 Abbott Laboratories Transgenic animals producing oligosaccharides and glycoconjugates
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose

Also Published As

Publication number Publication date
US6083934A (en) 2000-07-04
DE69825260T2 (de) 2005-08-04
JP2001517950A (ja) 2001-10-09
EP0973413A1 (de) 2000-01-26
EP0973413B2 (de) 2011-11-09
DK0973413T3 (da) 2004-11-29
CA2285066C (en) 2010-06-08
NO994722D0 (no) 1999-09-28
ES2229486T5 (es) 2012-01-10
DK0973413T4 (da) 2012-02-27
NO315254B1 (no) 2003-08-11
PT973413E (pt) 2004-11-30
WO1998043495A1 (en) 1998-10-08
CA2285066A1 (en) 1998-10-08
DE69825260D1 (de) 2004-09-02
DE69825260T3 (de) 2012-04-26
JP4148535B2 (ja) 2008-09-10
EP0973413B1 (de) 2004-07-28
NO994722L (no) 1999-09-28
US5906982A (en) 1999-05-25
ES2229486T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
ATE271788T1 (de) Lacto-n-neotetraose enthaltende ernährungszusammensetzungen
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
MY115662A (en) Novel compounds with analgesic effect
ATE232907T1 (de) Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidation
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
ES8801217A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
MY101600A (en) An agricultural composition with reduced toxicity to fishes and shellfishes.
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
NO952575L (no) Flytende vanillinblanding, dens fremstilling og anvendelse
BG100691A (en) Herbicide composition
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
JPS542337A (en) Bactericidal composition for medical use
AU6722498A (en) Disubstituted biphenyloxazolines
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
YU23498A (sh) Herbicidni 3,5-difluoropiridini
ES2097706A1 (es) Composicion repeledora de cucarachas.
ATE204294T1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
AU3903701A (en) Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
TW325469B (en) 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0973413

Country of ref document: EP